Summary. Relaxin was extracted from the ovaries of pregnant rats. Material possessing uterine relaxing activity in vitro was eluted in three peaks from Sephadex G.50 columns. The 'G3 peak' material eluting in a position comparable to that of porcine relaxin inhibited myometrial activity of rats in vivo, improved the rate of rise of pressure of intrauterine pressure cycles in vivo, and, when administered to rats following progesterone and oestrogen priming, increased the distensibility of the cervix in vitro. This material also stimulated inter-pubic ligament formation in the mouse. This rat relaxin material therefore exhibits biological actions in the rat similar to those previously assigned to porcine relaxin.
Introduction
Relaxin is a polypeptide hormone which to date has been shown to have three main biological actions, i.e. inhibition of uterine contraction (uterine relaxing factor activity), elongation of the interpubic ligament and softening of the cervix (for review see Porter, 1979a) .
Because large amounts of the polypeptide can be extracted from the corpora lutea of the pregnant sow (Hisaw & Zarrow, 1950) most studies have utilized porcine relaxin. However, relaxin exhibits species specificity (Porter, 1979a) and ovarian extracts from pregnant rats show little or no cross-reactivity in a radioimmunoassay (RIA) which we developed for porcine relaxin based on that of Bryant-Greenwood & Greenwood (1979) . It may be important therefore to isolate relaxin from each species of experimental interest in order to confirm its physiological actions in those species and to develop specific assays.
During our work of extracting and purifying rat relaxin from the ovaries of pregnant rats, details of the purification of rat relaxin by a different method and of an homologous RIA were published by Sherwood & Crnekovic (1979) and . We have therefore extended our findings by examining the physiological actions of rat relaxin.
Materials and Methods

Extraction of rat ovaries
Groups of 20-30 female Wistar rats from a closed colony at the University of Bristol were mated at regular intervals. On Days 18, 19 or 20 of pregnancy the animals were killed by decapitation and trunk blood was collected into ice-cold heparinized tubes. The reproductive tracts were then removed and placed on solid C02. When blood was not required the animals were killed by breaking their necks. Plasma obtained from the blood was extracted immediately for relaxin by the method of Albert & Money (1946) . Tissue from the reproductive tract was either used immediately or stored at -20°C.
The relaxin extraction method was based largely on that of Sherwood & O'Byrne (1974 Organ-bath tests for uterine relaxing activity Pro-oestrous virgin rats were used. Each animal was killed by a blow on the head and the uterus was removed quickly into ice-cold Krebs-Henseleit buffer (g/1: NaCl 6-9; KC1 0-35; CaCl2.6H20 0-55; MgS04.7H20 0-29; NaHC03 2-1; KH2P04 016; glucose 2-00), pH 7-5. Fat was trimmed off, the cervix and ovaries removed and the uterine horns opened longitudinally. Each horn was cut into 6 strips approximately 3 mm 6 mm long which were kept in ice-cold buffer until used. Platinum/iridium electrodes were inserted into each end of the strip and the assembly placed in a 10 ml organ-bath containing Krebs After 10 successive contractions of uniform tension had been recorded, a sample of test material dissolved in up to 0-5 ml Krebs-Henseleit buffer (or in 0-1 ml distilled water) was introduced into the bath. After a further 10 contractions had been recorded the bath was washed out 3 times with fresh buffer. If the sample did not affect the activity of the strip another sample was introduced after at least a further 10 control contractions had been recorded. If, however, the sample had evoked an inhibitory response the uterine strip was discarded in order to avoid any problems with tachyphylaxis.
Results were calculated as the mean reduction in the amplitude of the 10 contractions recorded after introduction of the sample divided by the mean amplitude of the preceding 10 control contractions, and expressed as percentage inhibition.
Mouse pubic ligament test Virgin female mice of the MFI strain were primed with 5 pg oestradiol-17ß dipropionate (Sigma (London) Chemical Co., Poole, Dorset) administered s.c. in 0-1 ml corn oü on Day 0 and allocated at random into 5 groups. On Day 7 the 37 mice were treated with (i) vehicle, (n) known doses of porcine relaxin standard (Warner-Lambert Wl 164-lot 8; 150 GPU/mg) or (iii) the partly-purified extract from pregnant rat ovaries, dissolved in 0-1 ml 1% benzopurpurin (Raymond A. Lamb, London). The mice were killed with ether 24 h later and the pelvic girdles were dissected free of soft tissue. The length of the interpubic ligament was estimated with the aid of transillumination and a dissecting microscope (Steinetz et ai, 1960) . Uteri exhibiting no macroscopic evidence of oestrogen priming were rejected. There were 6-9 animals in each group and mean differences from the control group values were compared by Student's t test.
Experiment 1: the action ofpregnant rat ovarian extract on myometrial activity in vivo Rats that had littered were ovariectomized and equipped with latex balloons filled with 0-45 ml distilled water (Armitage, 1971 
Results
Extraction
Ovarian extracts invariably showed high uterine relaxing activity but no extracts of pregnant rat plasma, cervix, maternal placenta or inter-placental uterus possessed such activity when tested in the organ bath either as crude extracts or after partial purification. Both types of extracts of fetal placenta however inconsistently exhibited positive but low uterine relaxing activity.
The ovarian extract was a grey/white powder obtained in yields of about 6-8 mg/g wet weight of ovarian tissue extracted.
Purification
Ovarian extract from pregnant rats was purified routinely by gel filtration. A typical result from the Sephadex G50 gel filtration is shown in Text- fig. 1 . Three peaks of activity were normally found and these were designated , 'G2' and 'G3' in order of descending molecular size. The 'G3 peak' material was eluted in a position similar to that of porcine relaxin suggesting that the two substances are of similar molecular size (Text- fig. 1 fig. 2 ). That the inhibitory effect observed in the fractions was attributable to relaxin was supported by (1) the simüarity of effect with that of porcine relaxin; (2) the virtual exclusion of other known myometrial inhibitors such as steroids, prostaglandins, catecholamines and histamine by the extraction and fractionation procedures; (3) the faüure of extracts from the ovaries of non-pregnant rats to inhibit the myometrium; and (4) the faüure of fractions (in amounts adequate to inhibit the myometrium in the test system by at least 75%) to affect the activity of the rat ileum. The material was also able to induce cervical softening and separate the pubic symphysis, the latter being specific for relaxin.
Mouse pubic ligament test Table 1 shows the increases in the length of the interpubic ligament induced by 'G3 peak' material. The 'G3 peak' material exhibited a similar activity (w/w) to the standard in this test. Complete cessation of myometrial activity occurred for about 20 min in each of 7 non-pregnant anaesthetized rats given an i.v. injection of 'G3 peak' material (P < 0-001) (Text- fig. 3 ). Activity recovered thereafter at a higher frequency in individual rats than had been recorded before treatment but, because of variations in the period of total quiescence, average frequency did not exceed control levels until 60-70 min after treatment. During the period of myometrial quiescence the uterus remained responsive to 5 mU oxytocin i. fig. 3 . Intrauterine (IUP) and carotid arterial (BP) pressure records from an anaesthetized rat treated with three doses of 10 pg 'G3 peak' material: (a) shows spontaneous recovery from the treatment, (b) responses to 'G3 peak' material followed by 5 mU oxytocin (i.v.) and (c) responses to 'G3 peak' material followed by 5 pg PGF-2a intra-arterially.
The rate of rise of intrauterine pressure during IUP cycles was significantly increased during recovery from relaxin (Text-fig. 4 ). The overall rates of pressure rise were 2-63 ± 0-54 mmHg/sec before treatment with the 'G3 peak' material and 6-55 ± 1-39 mmHg/sec during the recovery period. The corresponding figures for the maximum rates of rise were 4-74 + 0-84, and 14-26 ± 2-75 mmHg/sec. In both cases the differences were statistically significant (P < 0-005).
Although the mean and maximum amplitudes of IUP cycles fell slightly during the first 10 min, i.e. before complete quiescence occurred after treatment with 'G3 peak' material, during recovery these measures of amplitude were not significantly different from the pretreatment levels.
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Text- fig. 4 . Intrauterine pressure, recorded at a chart speed of 3 mm/sec, from a conscious unrestrained rat. The rate at which pressure rises in the pressure cycles before treatment with 'G3 peak' relaxin is less than that observed in pressure cycles recorded during recovery from relaxin inhibition.
Experiment 3: effect of 'G3 peak' material on tension development during stretch of the cervix As shown in Table 2 , the tensions developed initially and after adaptation for 30 min were significantly less (P < 0-05, d.f. = 9) in the cervices from animals treated with 'G3 peak' material than those from control animals at all extensions > 1 mm above 'resting length'. Values are mean ± s.e.m. for 7 control samples and 4 treated with 'G3 peak' material.
* Significantly different from control value, < 0-05.
Discussion
These experiments demonstrate for the first time that rat relaxin exerts physiological effects in the rat similar to those that have previously been described only for porcine relaxin. The rat preparation also stimulated pubic ligament formation in mice, a property specific for relaxin. The ability of rat relaxin to inhibit myometrial activity in vivo and in vitro, and to soften the uterine cervix is consistent with the reports of McMurtry, Kwok & Bryant-Greenwood (1978) , Mercado-Simmen, Bryant-Greenwood & Greenwood (1980) and Cheah & Sherwood (1980) that these tissues possess receptors for relaxin as evidenced by their binding of 12SI-labelled relaxin. These findings support the suggestion (Porter, 1979b) (Porter, Downing & Bradshaw, 1979) . The finding that the rate of rise of intrauterine pressure was significantly elevated after treatment suggests that relaxin improves myometrial co-ordination. This conclusion is based on theoretical (Coren & Csapo, 1963) and experimental (Csapo & Takeda, 1965) evidence that the rate of development of pressure within a uterus is determined by the degree of electrical synchronization within the myometrium. The finding that rat relaxin has this property is consistent with similar findings reported for porcine relaxin (Downing, Bradshaw & Porter, 1980) , and lends additional support to the contention that relaxin may mediate some of the actions of oestrogens on the uterus (Steinetz, Beach, Blye & Kroc, 1957) because oestradiol is also known to enhance the rate of rise of intrauterine pressure (Downing, Lye, Bradshaw & Porter, 1978) , amongst other actions resembling those of relaxin (Steinetz et ai, 1957) .
The ability of rat relaxin to soften the cervix contributes to the growing evidence (Porter, 1981) that relaxin is implicated in cervical softening pre partum. However, the degree of softening achieved, even in conjunction with a steroid treatment regimen designed to simulate the endocrine environment of pregnancy, was much less than occurs naturally at term. This suggests that other factors or mechanisms may also be involved. The 'G3 peak' material evoked an increase in the length of the interpubic ligament of the oestrogen-primed mouse which appeared to be dose-dependent. The increases were of a simüar magnitude to those caused by comparable doses of the Warner-Lambert porcine relaxin standard so that the 'G3 peak' material also appeared to contain about 150 GPU relaxin activity/mg. Larkin (1974) has suggested that rat and porcine relaxins may produce dose-response curves which have different slopes, but our data suggest that highly purified rat relaxin is no more active on the mouse pubic symphysis than is relatively impure porcine relaxin. This is in agreement with the findings of Larkin (1974) and of , although the explanation is unclear.
In conclusion this report is the first demonstration that relaxin extracted from a particular species exerts the major biological actions ascribed to the hormone in the same species, and therefore justifies further investigation of the significance of this hormone in the normal reproductive functions of the animal.
Further purification of rat relaxin 'G3 peak' material by ion exchange chromatography on a carboxymethyl cellulose (Whatman CM52) column during the course of this work yielded a single sharp peak possessing uterine relaxing activity. From an identical column porcine relaxin eluted in 2 or 3 broad peaks at a higher salt concentration.
This finding is in contrast to the report of who obtained 2 peaks of rat relaxin but is supported by the report of Walsh & Niall (1980) who, using a different extraction method, have obtained rat and porcine relaxins as single molecular forms. Present evidence therefore indicates that there is only a single rat relaxin.
